FDA

Latest News

 yodiyim-stock.adobe.com
FDA Sets Review Date for Chronic Lung Disease Therapy

February 7th 2025

Regulators have set a goal of Aug. 12, 2025, for brensocatib to treat patients with non-cystic fibrosis bronchiectasis, a chronic lung disease.

 RFBSIP-stoc
FDA Approves Susvimo for Diabetic Macular Edema

February 4th 2025

FDA Approves Third Biosimilar of Actemra
FDA Approves Third Biosimilar of Actemra

February 3rd 2025

FDA Approves Journavx, New Nonopioid Med, for Acute Pain
FDA Approves Journavx, New Nonopioid Med, for Acute Pain

January 31st 2025

 mbruxelle-stock.adobe.com
FDA Approves Ozempic to Reduce Kidney Disease in Type 2 Diabetes

January 28th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.